11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia

Details for Australian Patent Application No. 2003207717 (hide)

Owner Merck & Co., Inc.

Inventors Hermanowski-Vosatka, Anne; Balkovec, James M; Thieringer, Rolf; Patel, Gool F; Waddell, Sherman T; Graham, Donald W; Maletic, Milana; Mundt, Steven S; Olson, Steven H; Aster, Susan D

Agent Spruson & Ferguson

Pub. Number AU-B-2003207717

PCT Number PCT/US03/02558

PCT Pub. Number WO2003/065983

Priority 60/353,592 01.02.02 US

Filing date 28 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 3 July 2008

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/437 (2006.01)

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4439 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 249/12 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 249/14 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/353,592 01.02.02 US

25 September 2003 Application Open to Public Inspection

  Published as AU-B-2003207717

3 July 2008 Application Accepted

  Published as AU-B-2003207717

30 October 2008 Standard Patent Sealed

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003207718-LOAD SINGULATION SYSTEM AND METHOD

2003207716-INCINERATOR SEALS